Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis

Inclusion Criteria: 1. Signed Informed Consent Form 2. \> 18 years of age 3. Tinea pedis (Athlete's foot) confirmed with positive mycological culture for a dermatophyte 4. Total score of 6-16 when grading the eight sign and symptoms of tinea pedis (erythema, erosions, macerations, pruritus, fissures, burning/stinging, hyperkeratosis, odour) using a 4-point severity scale (0=absent, 1= mild, 2= moderate, 3=severe) o Score of 2 or higher required in at least one of the following: erythema, pruritus, macerations or odour 5. Score of at least 2 (moderate) required in at least one of the following: heel cracks (rhagades), calluses and dry feet (hyperkeratosis) using a 5-point severity scale (0=absent, 1= mild, 2= moderate, 3= advanced, 4=severe) age Exclusion Criteria: 1. Patients with negative mycological culture 2. Severe tinea pedis interdigitalis (Athlete's foot) total score of grading sign and symptoms \> 16 3. Women pregnant or lactation at time of enrolment 4. Patients using medicinal topical antifungal therapy within 4 weeks prior to study start 5. Treatment with oral terbinafine, itraconazole or fluconazole within 6 months prior to start of study 6. Treatment with other systemic antifungals within 12 weeks prior to start of study 7. Treatment with systemic corticosteroids or immunosuppressants within 6 weeks prior to start of study 8. Any other condition that as judged by the investigator may make follow-up or investigations inappropriate 9. Any patient that according to the Declaration of Helsinki is unsuitable for enrollment